LEVELS – A Whole New Level cover image

#283 - Brain health explained: Insulin resistance, biomarkers, and Alzheimer’s risk | Dr. David Perlmutter & Mike Haney

LEVELS – A Whole New Level

00:00

Why Alzheimer's Research Chased Ineffective Single-Target Drugs

Mike asks why the field pursued monotherapies; Perlmutter explains pharmaceutical incentives and the multifactorial nature of dementia.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app